Literature DB >> 23312281

Vascular complications of diabetes: mechanisms of injury and protective factors.

Christian Rask-Madsen1, George L King.   

Abstract

In patients with diabetes, atherosclerosis is the main reason for impaired life expectancy, and diabetic nephropathy and retinopathy are the largest contributors to end-stage renal disease and blindness, respectively. An improved therapeutic approach to combat diabetic vascular complications might include blocking mechanisms of injury as well as promoting protective or regenerating factors, for example by enhancing the action of insulin-regulated genes in endothelial cells, promoting gene programs leading to induction of antioxidant or anti-inflammatory factors, or improving the sensitivity to vascular cell survival factors. Such strategies could help prevent complications despite suboptimal metabolic control.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23312281      PMCID: PMC3546345          DOI: 10.1016/j.cmet.2012.11.012

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  100 in total

1.  Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study.

Authors:  Hillary A Keenan; Tina Costacou; Jennifer K Sun; Alessandro Doria; Jerry Cavellerano; Joseph Coney; Trevor J Orchard; Lloyd Paul Aiello; George L King
Journal:  Diabetes Care       Date:  2007-05-16       Impact factor: 19.112

2.  Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP.

Authors:  Edward Thorp; Gang Li; Tracie A Seimon; George Kuriakose; David Ron; Ira Tabas
Journal:  Cell Metab       Date:  2009-05       Impact factor: 27.287

3.  Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.

Authors:  Berend Isermann; Ilya A Vinnikov; Thati Madhusudhan; Stefanie Herzog; Muhammed Kashif; Janusch Blautzik; Marcus A F Corat; Martin Zeier; Erwin Blessing; Jun Oh; Bruce Gerlitz; David T Berg; Brian W Grinnell; Triantafyllos Chavakis; Charles T Esmon; Hartmut Weiler; Angelika Bierhaus; Peter P Nawroth
Journal:  Nat Med       Date:  2007-11-04       Impact factor: 53.440

Review 4.  Vascular endothelial growth factor and diabetic nephropathy.

Authors:  Sheldon Chen; Fuad N Ziyadeh
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

5.  Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.

Authors:  Vicki Thallas-Bonke; Suzanne R Thorpe; Melinda T Coughlan; Kei Fukami; Felicia Y T Yap; Karly C Sourris; Sally A Penfold; Leon A Bach; Mark E Cooper; Josephine M Forbes
Journal:  Diabetes       Date:  2007-10-24       Impact factor: 9.461

Review 6.  The pathogenesis of diabetic nephropathy.

Authors:  Suma Dronavalli; Irena Duka; George L Bakris
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-07-08

7.  Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis.

Authors:  Evis Harja; Jong Sun Chang; Yan Lu; Michael Leitges; Yu Shan Zou; Ann Marie Schmidt; Shi-Fang Yan
Journal:  FASEB J       Date:  2008-11-26       Impact factor: 5.191

8.  Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B(1) and B(2) receptors.

Authors:  M Abdouh; S Talbot; R Couture; H M Hasséssian
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

9.  Vegfa protects the glomerular microvasculature in diabetes.

Authors:  Gavasker A Sivaskandarajah; Marie Jeansson; Yoshiro Maezawa; Vera Eremina; Hans J Baelde; Susan E Quaggin
Journal:  Diabetes       Date:  2012-11       Impact factor: 9.461

10.  Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress.

Authors:  Takafumi Senokuchi; Chien-Ping Liang; Tracie A Seimon; Seongah Han; Michihiro Matsumoto; Alexander S Banks; Ji-Hye Paik; Ronald A DePinho; Domenico Accili; Ira Tabas; Alan R Tall
Journal:  Diabetes       Date:  2008-08-26       Impact factor: 9.461

View more
  210 in total

1.  Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis.

Authors:  H N Ashiqur Rahman; Hao Wu; Yunzhou Dong; Satish Pasula; Aiyun Wen; Ye Sun; Megan L Brophy; Kandice L Tessneer; Xiaofeng Cai; John McManus; Baojun Chang; Sukyoung Kwak; Negar S Rahman; Wenjia Xu; Conrad Fernandes; John Michael Mcdaniel; Lijun Xia; Lois Smith; R Sathish Srinivasan; Hong Chen
Journal:  Circ Res       Date:  2016-02-15       Impact factor: 17.367

2.  Endothelial Dysfunction as a Link Between Cardiovascular Risk Factors and Peripheral Neuropathy in Diabetes.

Authors:  Matthieu Roustit; Jordan Loader; Carly Deusenbery; Dimitrios Baltzis; Aristidis Veves
Journal:  J Clin Endocrinol Metab       Date:  2016-07-11       Impact factor: 5.958

Review 3.  The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases.

Authors:  Xizhen Xu; Rui Li; Guangzhi Chen; Samantha L Hoopes; Darryl C Zeldin; Dao Wen Wang
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

4.  A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes.

Authors:  Carmen M Warren; Safiyyah Ziyad; Anaïs Briot; Aaron Der; M Luisa Iruela-Arispe
Journal:  Sci Signal       Date:  2014-01-07       Impact factor: 8.192

Review 5.  Metabolic Regulation of Angiogenesis in Diabetes and Aging.

Authors:  Naoki Sawada; Zolt Arany
Journal:  Physiology (Bethesda)       Date:  2017-07

Review 6.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Authors:  Elia J Duh; Jennifer K Sun; Alan W Stitt
Journal:  JCI Insight       Date:  2017-07-20

Review 7.  Linking diabetic vascular complications with LncRNAs.

Authors:  Amy Leung; Vishnu Amaram; Rama Natarajan
Journal:  Vascul Pharmacol       Date:  2018-02-03       Impact factor: 5.773

8.  MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy.

Authors:  Ying Wang; Wenwen Lin; Jianghua Ju
Journal:  Cell Cycle       Date:  2020-04-15       Impact factor: 4.534

Review 9.  Clinical therapeutic strategies for early stage of diabetic kidney disease.

Authors:  Munehiro Kitada; Keizo Kanasaki; Daisuke Koya
Journal:  World J Diabetes       Date:  2014-06-15

10.  Associations between metabolic dysregulation and circulating biomarkers of fibrosis: the Cardiovascular Health Study.

Authors:  Isha Agarwal; Nicole L Glazer; Eddy Barasch; Luc Djousse; John S Gottdiener; Joachim H Ix; Jorge R Kizer; Eric B Rimm; David S Siscovick; George L King; Ken J Mukamal
Journal:  Metabolism       Date:  2015-07-21       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.